Industry News
·Jan 29, 2020
Aimmune’s peanut allergy drug poised to become world-first
By the end of January 2020, the FDA will have announced its decision regarding approval of the Aimmune Therapeutics peanut allergy drug Palforzia (AR101). The company recently presented information about their new drug, and others they have in the pipeline,…